Wilson, Charles - The David and Lucile Packard Foundation

I am the founder and CEO of Unum Therapeutics, which develops novel cellular immunotherapies to treat cancer. Unum has developed an Antibody-Coupled T-cell Receptor (ACTR) that enables a patient’s T cells to be targeted to attack tumor cells via a co-administered tumor-specific antibody. Clinical proof-of-concept for ACTR has been provided in an ongoing clinical study Continue Reading

Our Team - E.O. Wilson Biodiversity Foundation

The David and Lucile Packard Foundation Headquarters

ComNet18 Attendees by The Communications Nework - Issuu

The Future of Children by Military Child Education Coalition - Issuu

Faculty Honors 2014-2015 – Discovery: Research at Princeton

Lena wilson hi-res stock photography and images - Alamy

II. Private Contributions, Report of the Treasurer for the Year Ended December 31, 2008

Our Team - E.O. Wilson Biodiversity Foundation

2007 Private Contributions, Report of the Treasurer for the Year Ended December 31, 2007